Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leukemia, Myelocytic, Acute
|
6892 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.780 | 1.000 | 16 | 2010 | 2019 | |||||
Malignant Neoplasms
|
1641 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.030 | 1.000 | 3 | 2013 | 2015 | |||||
MYELODYSPLASTIC SYNDROME
|
95 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.720 | 1.000 | 3 | 2010 | 2016 | |||||
Primary malignant neoplasm
|
1374 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.030 | 1.000 | 3 | 2013 | 2015 | |||||
Acute Erythroblastic Leukemia
|
5 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.020 | 1.000 | 2 | 2015 | 2017 | |||||
Adult Erythroleukemia
|
4 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.020 | 1.000 | 2 | 2015 | 2017 | |||||
Childhood Leukemia
|
140 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.020 | 1.000 | 2 | 2015 | 2015 | |||||
D-2-HYDROXYGLUTARIC ACIDURIA 2
|
2 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.800 | 1.000 | 2 | 2010 | 2011 | |||||
Erythroleukemia (Erythroid/Myeloid)
|
4 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.020 | 1.000 | 2 | 2015 | 2017 | |||||
leukemia
|
144 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.020 | 1.000 | 2 | 2015 | 2015 | |||||
Blastic plasmacytoid dendritic cell neoplasm
|
2 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Chronic myeloproliferative disorder
|
47 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||
Colorectal Neoplasms
|
609 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Combined D-2- and L-2-hydroxyglutaric aciduria
|
14 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
D-2-hydroxyglutaric aciduria
|
6 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
D-2-HYDROXYGLUTARIC ACIDURIA 1
|
15 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Multiple Myeloma
|
865 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||
Primary Myelofibrosis
|
29 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||
Squamous cell carcinoma of the head and neck
|
348 | 0.708 | 0.320 | 15 | 90088702 | missense variant | C/A;T | snv | 3.2E-05 | 0.700 | 1.000 | 1 | 2016 | 2016 |